Reliq Health Technologies Inc. (TSXV:RHT) will be working with Canaccord Genuity Corp. (TSXV:CF) and Gravitas Securities Inc. (private) on a brokered private placement offering. Canaccord and Gravitas will be co-leading the private placement, which will consist of up to 6,696,428 units at $1.12 per unit, totaling $7.5 million.

Each unit will be made up of one common share in the company and half a transferable common share purchase warrant. Each warrant can acquire an additional share for $1.75 for up to two years after the closing date. The funds from the private placement will be used for general working capital, product development, and customer acquisition.

The CEO of Reliq Health, Lisa Crossley, has said of the agreement, “We are pleased to have the continued support of two of Canada’s leading independent brokerage firms.”

Featured Image: Depositphotos/© Wavebreakmedia